[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354449-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354449-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","clinical-significance-of-tumor-invasion-gene-profiling-in-earlystage-hormone-receptorpositive-breast-cancer-a-crosssectional-study","Clinical Significance of Tumor Invasion Gene Profiling in Early‐Stage Hormone Receptor‐Positive Breast Cancer - A Cross‐Sectional Study","","Advanced breast cancer is a leading cause of cancer-associated death, making biomarker discovery critical for identifying patients likely to progress and benefit from more aggressive therapy. Hormone receptor-positive tumors comprise ~70% of breast cancers, yet routine clinical markers do not assess invasion and metastasis. This cross-sectional study analyzes 239 early-stage hormone receptor-positive cases using FFPE samples and TaqMan assays to evaluate five invasion/metastasis genes linked to poor prognosis, including CTSV, MYBL2, SCUBE2, MMP11, and CD68.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/clinical-significance-of-tumor-invasion-gene-profiling-in-earlystage-hormone-receptorpositive-breast-cancer-a-crosssectional-study/354449/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/clinical-significance-of-tumor-invasion-gene-profiling-in-earlystage-hormone-receptorpositive-breast-cancer-a-crosssectional-study/354449.png","ImageObject",300,407,{"name":42,"@type":43},"Fans","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the goal of the study on early-stage hormone receptor-positive breast cancer?","Question",{"text":63,"@type":64},"To identify gene-expression patterns associated with established pathology markers of poor prognosis, helping recognize tumors more likely to progress to advanced disease and metastasize.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which genes were selected for analysis, and how were gene expression measured?",{"text":68,"@type":64},"Five genes—MMP11, CTSV, CD68, SCUBE2, and MYBL2—were assessed using TaqMan expression assays; MYBL2 amplification was evaluated with fluorescent in situ hybridization (FISH).",{"name":70,"@type":61,"acceptedAnswer":71},"What key associations were found between gene expression and clinical/pathological variables?",{"text":72,"@type":64},"CTSV expression correlated with larger tumor size and lymph node involvement, MYBL2 expression associated with higher tumor grade, and SCUBE2 showed an inverse association with tumor grade.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354449,1791058420,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Health Science Reports   \nORIGINAL RESEARCH   \nClinical Significance of Tumor Invasion Gene Profiling in Early‐Stage Hormone Receptor‐Positive Breast Cancer:  \nA Cross‐Sectional Study  \nShayan Forghani1 | Hamid Rezvani2 | Arman Forghani1 | Fatemeh Mahdavi Sabet1  | Atieh Akbari1 | Sanaz Tabarestani1  | Hamid Reza Mirzaee1  \n1Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran | 2Department of Hematology‐oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran  \nCorrespondence: Sanaz Tabarestani ([sanaztf@gmail.com](sanaztf@gmail.com); [stabarestani@sbmu.ac.ir](stabarestani@sbmu.ac.ir))  \nReceived: 3 July 2025 | Revised: 25 June 2026 | Accepted: 29 June 2026  \nKeywords: breast cancer | CTSV | gene expression | metastasis | MYBL2 | SCUBE2  \nABSTRACT  \nBackground and Aims: Advanced breast cancer is a leading cause of cancer‐associated death in women. It is critical to find biomarkers to identify patients who are more prone to progress to advanced disease and would be better served with more aggressive treatments. Hormone receptor‐positive breast cancers make up about 70% of all breast cancers. The analysis of gene amplification and expression has been utilized to classify breast tumors into medically useful risk groups. In the present study, we selected five genes (MMP11, CTSV, CD68, SCUBE2, and MYBL2) that are important in tumor invasion and metastasis to identify a pattern associated with well‐established pathology markers indicative of poor prognosis in early‐stage hormone receptor‐positive breast cancers.  \nMethods: Two hundred and thirty‐nine early‐stage hormone receptor‐positive breast cancer patients were analyzed. Patients were required to have FFPE (formalin‐fixed paraffin‐embedded) samples from the primary tumor. Expression of the selected genes was determined using TaqMan expression assays. MYBL2 amplification was examined using fluorescent in situ hybridization (FISH) .  \nResults: Expression of CTSV was significantly associated with increasing tumor size (p = 0.001) and lymph node involvement (p = 0.016) . In multivariate analysis, CTSV expression remained significantly associated with lymph node involvement (p = 0.049) . Expression of MYBL2 was associated with higher tumor grade (p = 0.001) . We identified MYBL2 amplification in one sample. Expression of SCUBE2 was inversely associated with tumor grade (p = 0.04) . Receiver‐operator characteristic (ROC) analysis was used to predict lymph node involvement using clinicopathologic features (age at diagnosis, tumor size, and histologic grade), and the five gene expression markers, which resulted in AUC = 0.83.  \nConclusion: We found a significant association between CTSV, MYBL2, and SCUBE2 expression and pathological variables of poor prognosis. Our study reveals that analysis of the expression of these genes may help identify early‐stage hormone receptor‐ positive breast tumors that are more likely to metastasize and need more intense treatment modalities.  \n1 | Introduction  \nGlobally, breast cancer is the leading malignancy diagnosed among women. Breast cancer is a heterogeneous disease, and  \nmultiple subtypes have been identified. Hormone receptor‐ positive breast cancers, which express either estrogen receptor (ER) or progesterone receptor (PR), make up about 70% of all breast cancers [1] . Advances in the understanding of the  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s) . Health Science Reports published by Wiley Periodicals LLC.  \nHealth Science Reports, 2026; 9:e72780 1 of 11  \n[https://doi.org/10.1002/hsr2.72780](https://doi.org/10.1002/hsr2.72780)  \nbiological heterogeneity of breast cancer have driven the development of novel therapeutic strategies, resulting in substantial improvements in patient survival. Despite all these developme","cbCaiaJQIg1LeV3R","https://ap.wps.com/l/cbCaiaJQIg1LeV3R","pdf",2019930,11,"English","# Abstract\n## Background and Aims\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the goal of the study on early-stage hormone receptor-positive breast cancer?\",\"answer\":\"To identify gene-expression patterns associated with established pathology markers of poor prognosis, helping recognize tumors more likely to progress to advanced disease and metastasize.\"},{\"question\":\"Which genes were selected for analysis, and how were gene expression measured?\",\"answer\":\"Five genes—MMP11, CTSV, CD68, SCUBE2, and MYBL2—were assessed using TaqMan expression assays; MYBL2 amplification was evaluated with fluorescent in situ hybridization (FISH).\"},{\"question\":\"What key associations were found between gene expression and clinical/pathological variables?\",\"answer\":\"CTSV expression correlated with larger tumor size and lymph node involvement, MYBL2 expression associated with higher tumor grade, and SCUBE2 showed an inverse association with tumor grade.\"}]","Clinical Significance of Tumor Invasion Gene Profiling in Early‐Stage Hormone Receptor‐Positive Breast Cancer - A Cross‐Sectional Study | PDF",1790110688,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d9ed1fd525fe0425939146ac20959f8.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bd0a512de96150f518e812ce399220b.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22cb40363db8f21122d24edf09bf7ad5.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4d198d444871ffaccaee8927dc595ef.webp",980,1287]